| Purpose: Paul on the herbal treatment of ischemic cardiomyopathy Heart failure patients in remission Qi phlegm on collateral observation of clinical efficacy,To provide effective clinical treatment.Method: This study included ischemic cardiomyopathy heart failure of qi deficiency and phlegm relief network card 60 patients,30 cases were randomly divided into treatment group and control group of 30 patients。Two groups in age, gender, disease duration and other general information was no significant difference。Chinese medicine treatment group for Heart Protection,Control group that enalapril maleate (YS) and metoprolol succinate (metoprolol) treatment,Before the treatment were observed after treatment of clinical symptoms and the clinical observations were observed.Result:1,Paul Heart treatment of ischemic cardiomyopathy patients with heart failure can improve cardiac function (NYHA) effect, compared with the control group is extremely significant difference (P<0.01);2,Paul Heart treatment could improve heart failure in ischemic cardiomyopathy patients with heart failure points, compared with the control group there was significant difference(P<0.01);3,Paul Heart treatment could improve heart failure patients with ischemic heart disease in symptom,The two groups after treatment in patients with clinical symptoms than the control group experimental group(P<0.05)。Unable to relieve fatigue in the experimental group,Face and limb edema,Expectoration,Epigastric fullness,Oliguria Symptoms than the control group(P<0.05),In the ease in which "fatigue weakness, cough, epigastric fullness and oliguria" has a very distinct advantage(P<0.01)。4,Paul Heart treatment of ischemic cardiomyopathy patients with heart failure can improve cardiac function ( EF ), Compared with the control group had significant differences(P<0.01)。5,Paul Heart treatment of ischemic cardiomyopathy patients with heart failure to improve cardiothoracic ratio,Experimental group compared with the control group group:Two groups before treatment, after treatment chest cardiothoracic ratio was no difference(P>0.05);Between the two groups:No difference between the two groups after treatment(P>0.05);6,Paul Heart treatment of ischemic cardiomyopathy patients with heart failure can improve cardiac function (EF) effects in the experimental group after treatment compared with control group has an extremely significant difference in the test group were significantly better than the control group (P<0.01 );7,Paul Heart treatment of ischemic cardiomyopathy, heart failure patients in remission to reduce the incidence of cardiovascular events, the experimental group and control group with significant differences after treatment, the experimental group was significantly lower than control group(P<0.05)8,Not appear in the course of treatment side effects,Safety testing before and after treatment no significant change in,Description Paul Heart in the course of treatment is safe and effective.Conclusion: Chinese Bao Heart failure treatment of ischemic heart disease remission Qi phlegm clinical effect on collateral Exact,Security,Can significantly improve Cardiac function,Clinical symptoms,Heart Failure,Quality of Life. |
PDF Full Text Request